Rossari Biotech Board Approves Q2 FY27 Unaudited Results

Rossari Biotech Ltd's Board of Directors convened on October 17, 2026, approving the unaudited financial results for the quarter and half-year ended September 30, 2026. The results, which were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, are now public. Additionally, the Board approved the leasing of land by its wholly-owned subsidiary, Rossari International Limited, for a greenfield manufacturing facility in the Kingdom of Saudi Arabia. Further details on the project plan and investment will be disclosed upon finalization.